Evaxion Biotech A/s (EVAX) Technical Analysis
$2.46▲0.41%
Market is closed - opens 7 PM, 02 Jul 2025
Insights
- Evaxion Biotech A/s is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Evaxion Biotech A/s stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Evaxion Biotech A/s stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Evaxion Biotech A/s stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 51.53 | Neutral |
Stochastic | 35.51, 38.4 | Neutral |
Ultimate Oscillator | 38.91 | Neutral |
Stochastic Relative Strength Index | 32.31, 34.05 | Neutral |
Moving Average Convergence Divergence | 0.08, 0.13 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.39 | Sell |
20 | 2.63 | Buy |
50 | 2.06 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.49 | Buy |
20 | 2.46 | Buy |
50 | 2.24 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.46 | Neutral |
20 | 2.68 | Sell |
50 | 2.28 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.47 | Sell |
20 | 2.6 | Buy |
50 | 2.47 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.43 | Sell |
20 | 2.51 | Sell |
50 | 2.7 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 2.88 |
Resistance L2 | 2.79 |
Resistance L1 | 2.62 |
Pivot Point | 2.52 |
Support L1 | 2.36 |
Support L2 | 2.26 |
Support L3 | 2.09 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.